1h Free Analyst Time
The pharmaceuticals market in germany is forecasted to grow by USD 24.9 billion during 2023-2028, accelerating at a CAGR of 6.79% during the forecast period. The report on the pharmaceuticals market in germany provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, increasing geriatric population, and growing number of M&A.
The pharmaceuticals market in germany is segmented as below:
By Distribution Channel
- Pharmacy
- Clinic
By Type
- Prescription
- Non-prescription
By Geographical Landscape
- Europe
The report on the pharmaceuticals market in germany covers the following areas:
- Pharmaceuticals market in germany sizing
- Pharmaceuticals market in germany forecast
- Pharmaceuticals market in germany industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the pharmaceuticals market in Germany: Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Johnson and Johnson Services Inc., MCM Klosterfrau Vertriebsgesellschaft mbH, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is robust growth of E-commerce."
According to the report, one of the major drivers for this market is the high investment in pharmaceutical industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Fresenius SE and Co. KGaA
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- MCM Klosterfrau Vertriebsgesellschaft mbH
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- STADA Arzneimittel AG
- Teva Pharmaceutical Industries Ltd.
